A limited, but accurate amount of detailed information about the radioactive isotopes used in the U.S. for medical procedures was collected from a local hospital and from a recent report on the U.S. Radiopharmaceutical Markets. These data included the total number of procedures, the specific types of procedures, the specific radioisotopes used in these procedures, and the dosage administered per procedure. The information from these sources was compiled, assessed, pruned, and then merged into a single, comprehensive and consistent set of results presented in this report. A summary of these results is given in Table 2 -1, and displayed as distributions in Figures 1a and 1b .
SUMMARY
A limited, but accurate amount of detailed information about the radioactive isotopes used in the U.S. for medical procedures was collected from a local hospital and from a recent report on the U.S. Radiopharmaceutical Markets. These data included the total number of procedures, the specific types of procedures, the specific radioisotopes used in these procedures, and the dosage administered per procedure. The information from these sources was compiled, assessed, pruned, and then merged into a single, comprehensive and consistent set of results presented in this report. A summary of these results is given in Table 2 -1, and displayed as distributions in Figures 1a and 1b .
The main findings from this preliminary survey are:
• A total of approximately 14.4 million medical procedures using radioisotopes were performed in the U.S. during 2001.
•
Of this total number of procedures during 2001, approximately 14.2 million were diagnostic procedures and 0.2 million were therapeutic procedures.
Although there were over 45 different commercially-available products used in over 75 different types of procedures, there were only 17 different isotopes used as radioactive agents in these products.
Of these 17 different isotopes, 12 are customarily administered to outpatients, and at 91.5 %, the isotope Tc-99m is by an overwhelming margin the most likely isotope to be administered. PIET 1.0 INTRODUCTION
Motivation
Each day in the U.S., over 39,000 medical procedures are performed that use radioactive isotopes. The overwhelming majority of these procedures are diagnostic in nature, and performed on an out-patient basis, i.e., most of these patients are free to move about in less than 24 hours after receiving the initial dose. Within that time period, most of these patients, traveling either as pedestrians or as passengers in vehicles, may cause alarms in various handheld or roadside radiation detectors. As local governments, as well as the Department of Homeland Security (DHS), Customs and Border Protection (CBP), implements their task to detect the illicit transport of nuclear material, the presence of radiation detectors will increase. The information on medical isotopes compiled in this survey should help in estimating the frequency and signatures of these "innocent" medical-based alarms.
Objective
The objective of this survey was to obtain accurate, up-to-date information about the radioactive isotopes used in the U.S. for medical procedures. The categories of data sought were the total number of such procedures, the specific types of procedures, the specific radioisotopes used in these procedures, and the dosage administered per procedure. The results presented in this Preliminary Survey do not represent an exhaustive search, and thus, should be considered as initial estimates. However, because the data used to obtain these preliminary results was of high quality, the results are expected to be reasonably accurate.
Data Sources
The data collected for this Preliminary Survey was obtained from the three sources (listed in the Reference section, below). These sources represent the Medical community, the Business & Finance community, and the Applied Nuclear Science community. Because these professions have been compiling information for different purposes, data from all three sources were needed to cover the range of our objectives.
To attain a single, comprehensive and consistent set of data, the information from the above three sources was compiled, assessed, pruned, and then merged to give the results shown in the body of this report. This information is used as an initial database for estimating the number and characteristic signature of medical incidents that may be detected by radiation portal monitors.
A summary of the Preliminary Survey results is given in Table 1 , and displayed as distributions in Figure 2 -1. The sets of data used to obtain this summary are listed in Table 2 , Table 3 , and From the data listed in Table 2 , it is seen a total of 2797 exams were performed on 2694 patients (i.e., 1.04 exams per patient) over the base-year period of 1 January 2001 -31 December 2001. The breakdown of these exams was 39.24 % male, 58.20 % female, and 2.41 % pediatric. The majority of these exams (91 %) were administered to out patients.
PIET-43741-TM-197 were extrapolated from the earlier data by using reasonably sound economic assumptions, and, depending on the particular market sector, amounted to compound annual growth rates from approximately 2 % to 6 %.
Because of the financial perspective of this report, the data from this source is organized according to the dominant market sectors, with emphasis on market-place drivers and projected revenues. Medical procedure types define the market sectors, where the topmost major division of the overall market is made between Diagnostic and Therapeutic procedures. These two major sectors are further broken down into their dominant components of three diagnostic sub-sectors and two therapeutic sub-sectors. These sub-sectors are Diagnostic-Cardiac, Diagnostic-PET/FDG, Diagnostic-Other, and Therapeutic-Bone and Therapeutic-Thyroid. All other therapeutic procedures, such as brachytherapy seeds (Cesium-137 implants) and Rhenium-188 therapy (following vascular stents for prevention of restenosis) were not considered significant for the purposes of this report; and thus were omitted. For each one of the five sub-sectors, we were able to obtain (or deduce) from the information in this report data on the total number of procedures, the dominant products used for these procedures, and the isotope used in each of the products. This information was distributed throughout the report as textual comments or in various tables.
According to this report, there were a total of 14.19 E+6 Diagnostic procedures compared to approximately 0.20 E+6 Therapeutic procedures performed in the U.S during 2001. The total number of Diagnostic procedures consists of three main categories: 0.29 E+06 FDG (Pet Scans), 5.83 E+06 Cardiology, and 8.08 E+06 Other. The detailed information used to correlate and cross-reference the number of procedures in each of these categories to specific isotopes is summarized in Table 3 (listed in the Data Tables section at the end of this report). 
APPLIED NUCLEAR SCIENCE DATA
The data from the field of Applied Nuclear Science was obtained from R.E. Schenter in the form of a private communication. Dr. Schenter has compiled a comprehensive list of 111 isotopes and their applications from the field of Nuclear Medicine. Note that most of these isotopes have been used in medical research projects, and are not commercially produced. Therefore they are unlikely to be seen at ports of entry into the U.S. Nevertheless, this list is important to have as a reference because some of these isotopes may eventually find their way into the commercial markets. 6.0 DATA TABLES 
